The administration and indeed the Congress is going to have to take a hard look at what we are asking the FDA to do, and with what resources. Every year, the number of new products FDA evaluates rises by 12 percent. The products are getting more complex, including technologies like genetically engineered drugs. In recent years, threats such as new viruses and food poisonings have risen. Congress allows the agency to charge drug makers fees that hire reviewers of prescription medicines.
Similar fees pay for quality inspections at mammography clinics.
An aging population is using more powerful drugs and medical devices, yet the FDA estimates it detects only 10 percent of injuries caused by improper use or unexpected side effects. New Commissioner Jane Henney has pledged to make rebuilding the science base a top priority. The nation's health is the subject here that we' re grappling with. All rights reserved.